STSS (Sharps Technology, Inc.) Gross Profit Margin

The gross profit margin demonstrates production efficiency, where -5.80 becomes the new value for this metric. Sharps Technology, Inc. (STSS) is scaling the production of instruments through partnerships with pharmacists by implementing secure smart systems. Revenues are based on the sale of innovative syringes that eliminate drug loss. A high ESG status and trust in the environmental sustainability of the products solidify the brand's position as a technological leader.
Analytical breakdowns and data insights for company Sharps Technology, Inc. (STSS)

Steady demand for medical innovations at Sharps Technology, Inc. (STSS) ensures business resilience regardless of macroeconomic fluctuations. Gross margin quantifies this potential, measuring the portion of revenue minus direct production costs to assess the efficiency of cost-of-goods-sold management. Analyzing the company's gross profit margin allows for the determination of the asset's fundamental margin of safety and prevents overpaying for strategic control over the company.